Jacobs Levy Equity Management’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-17,660
Closed -$81K 1125
2018
Q2
$81K Sell
17,660
-4,154
-19% -$21.7K ﹤0.01% 1001
2018
Q1
$157K Hold
21,814
﹤0.01% 951
2017
Q4
$156K Sell
21,814
-1,045
-5% -$8.84K ﹤0.01% 929
2017
Q3
$190K Buy
22,859
+3,965
+21% +$33.6K ﹤0.01% 874
2017
Q2
$193K Buy
18,894
+12,144
+180% +$120K ﹤0.01% 849
2017
Q1
$78K Sell
6,750
-2,130
-24% -$24.2K ﹤0.01% 873
2016
Q4
$113K Buy
+8,880
New +$141K ﹤0.01% 892
2016
Q3
Sell
-5,385
Closed -$57K 1200
2016
Q2
$57K Buy
5,385
+3,130
+139% +$61.5K ﹤0.01% 1123
2016
Q1
$43K Buy
+2,255
New +$43.4K ﹤0.01% 1071

Other funds holding NAVB